Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

24 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Safety and efficacy of irinotecan plus high-dose leucovorin and intravenous bolus 5-fluorouracil for metastatic colorectal cancer: pooled analysis of two consecutive southern Italy cooperative oncology group trials.
Comella P, Massidda B, Filippelli G, Natale D, Farris A, Buzzi F, Tafuto S, Maiorino L, Palmeri S, De Lucia L, Mancarella S, Leo S, Roselli M, Lorusso V, De Cataldis G. Comella P, et al. Among authors: de lucia l. Clin Colorectal Cancer. 2005 Sep;5(3):203-10. doi: 10.3816/ccc.2005.n.032. Clin Colorectal Cancer. 2005. PMID: 16197624 Clinical Trial.
Concurrent modulation of 5-fluorouracil with methotrexate and L-leucovorin: an effective and moderately toxic regimen for the treatment of advanced colorectal carcinoma. A multicenter phase II study of the Southern Italy Cooperative Oncology Group.
Comella P, Lorusso V, Casaretti R, De Lucia L, Cartení G, Manzione L, Mancarella S, De Lena M, Comella G. Comella P, et al. Among authors: de lucia l, de lena m. Tumori. 1999 Nov-Dec;85(6):465-72. doi: 10.1177/030089169908500608. Tumori. 1999. PMID: 10774567 Clinical Trial.
Biweekly irinotecan or raltitrexed plus 6S-leucovorin and bolus 5-fluorouracil in advanced colorectal carcinoma: a Southern Italy Cooperative Oncology Group phase II-III randomized trial.
Comella P, De Vita F, Mancarella S, De Lucia L, Biglietto M, Casaretti R, Farris A, Ianniello GP, Lorusso V, Avallone A, Cartenì G, Leo SS, Catalano G, De Lena M, Comella G. Comella P, et al. Among authors: de vita f, de lucia l, de lena m. Ann Oncol. 2000 Oct;11(10):1323-33. doi: 10.1023/a:1008375705484. Ann Oncol. 2000. PMID: 11106123 Free article. Clinical Trial.
Oxaliplatin plus raltitrexed and leucovorin-modulated 5-fluorouracil i.v. bolus: a salvage regimen for colorectal cancer patients.
Comella P, Casaretti R, Crucitta E, De Vita F, Palmeri S, Avallone A, Orditura M, De Lucia L, Del Prete S, Catalano G, Lorusso V, Comella G. Comella P, et al. Among authors: de vita f, de lucia l. Br J Cancer. 2002 Jun 17;86(12):1871-5. doi: 10.1038/sj.bjc.6600414. Br J Cancer. 2002. PMID: 12085178 Free PMC article. Clinical Trial.
Addition of either irinotecan or methotrexate to bolus 5-fluorouracil and high-dose folinic acid every 2 weeks in advanced colorectal carcinoma: a randomised study by the Southern Italy Cooperative Oncology Group.
Comella P, Crucitta E, De Vita F, De Lucia L, Farris A, Del Gaizo F, Palmeri S, Lannelli A, Mancarella S, Tafuto S, Maiorino L, Buzzi F, De Cataldis G; Associated Institutions of the Southern Italy Cooperative Oncology Group. Comella P, et al. Among authors: de cataldis g, de vita f, de lucia l. Ann Oncol. 2002 Jun;13(6):866-73. doi: 10.1093/annonc/mdf133. Ann Oncol. 2002. PMID: 12123331 Free article. Clinical Trial.
Irinotecan plus leucovorin-modulated 5-fluorouracil I.V. bolus every other week may be a suitable therapeutic option also for elderly patients with metastatic colorectal carcinoma.
Comella P, Farris A, Lorusso V, Palmeri S, Maiorino L, De Lucia L, Buzzi F, Mancarella S, De Vita F, Gambardella A. Comella P, et al. Among authors: de lucia l. Br J Cancer. 2003 Sep 15;89(6):992-6. doi: 10.1038/sj.bjc.6601214. Br J Cancer. 2003. PMID: 12966414 Free PMC article. Clinical Trial.
Oxaliplatin plus high-dose folinic acid and 5-fluorouracil i.v. bolus (OXAFAFU) versus irinotecan plus high-dose folinic acid and 5-fluorouracil i.v. bolus (IRIFAFU) in patients with metastatic colorectal carcinoma: a Southern Italy Cooperative Oncology Group phase III trial.
Comella P, Massidda B, Filippelli G, Palmeri S, Natale D, Farris A, De Vita F, Buzzi F, Tafuto S, Maiorino L, Mancarella S, Leo S, Lorusso V, De Lucia L, Roselli M. Comella P, et al. Among authors: de lucia l. Ann Oncol. 2005 Jun;16(6):878-86. doi: 10.1093/annonc/mdi185. Epub 2005 Apr 18. Ann Oncol. 2005. PMID: 15837702 Free article. Clinical Trial.
Cisplatin-epirubicin-paclitaxel weekly administration in advanced breast cancer: a phase I study of the Southern Italy Cooperative Oncology Group.
Frasci G, D'Aiuto G, Comella P, Apicella A, Thomas R, Capasso I, Di Bonito M, Cartenì G, Biglietto M, De Lucia L, Maiorino L, Piccolo S, Bianchi U, D'Aniello R, Lapenta L, Comella G. Frasci G, et al. Among authors: de lucia l. Breast Cancer Res Treat. 1999 Aug;56(3):239-52. doi: 10.1023/a:1006263226099. Breast Cancer Res Treat. 1999. PMID: 10573115 Clinical Trial.
24 results